Literature DB >> 2413072

Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.

W Savino, G Manganella, J M Verley, A Wolff, S Berrih, P Levasseur, J P Binet, M Dardenne, J F Bach.   

Abstract

17 thymomas were studied by indirect immunofluorescence for the presence of thymic hormones and antigens of the major histocompatibility complex (MHC). The thymoma epithelial cells (specifically identified by their keratin content) contained thymic hormones (thymulin and thymosin alpha 1), a finding corroborated by the observation of elevated thymulin serum levels. In contrast with normal or hyperplastic thymuses, thymoma epithelial cells did not express HLA-DR and HLA-DC antigens as assessed by immunofluorescence as well as immunoblot analyses. Conversely, MHC class I antigens (HLA-ABC) were normally expressed. Thus, we conclude that thymoma epithelial cells are endocrinologically active but are defective for the expression of some MHC products (class II molecules) known to play an essential role in intrathymic T cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413072      PMCID: PMC424007          DOI: 10.1172/JCI112069

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  The isolation of thymopoietin (thymin).

Authors:  G Goldstein
Journal:  Ann N Y Acad Sci       Date:  1975-02-28       Impact factor: 5.691

2.  Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.

Authors:  A L Goldstein; T L Low; M McAdoo; J McClure; G B Thurman; J Rossio; C Y Lai; D Chang; S S Wang; C Harvey; A H Ramel; J Meienhofer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

3.  Thymic hyperplasia and neoplasia: a review of current concepts.

Authors:  G D Levine; J Rosai
Journal:  Hum Pathol       Date:  1978-09       Impact factor: 3.466

4.  Evidence for a serum-factor secreted by the human thymus.

Authors:  J F Bach; M Papiernik; P Levasseur; M Dardenne; A Barois; H Le Brigand
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

5.  Decreased serum thymic factor activity in asthmatic children.

Authors:  E Garaci; R Ronchetti; V Del Gobbo; G Tramutoli; C Rinaldi-Garaci; C Imperato
Journal:  J Allergy Clin Immunol       Date:  1978-12       Impact factor: 10.793

6.  Characterization and expression of the HLA-DC antigens defined by anti-Leu 10.

Authors:  Y X Chen; R L Evans; M S Pollack; L L Lanier; J H Phillips; C Rousso; N L Warner; F M Brodsky
Journal:  Hum Immunol       Date:  1984-08       Impact factor: 2.850

7.  Plasma thymic hormone activity in patients with chronic mucocutaneous candidiasis.

Authors:  C H Kirkpatrick; L E Greenberg; S W Chapman; G Goldstein; V M Lewis; J J Twomey
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

8.  Tumours of the thymus. A review of 88 operation cases.

Authors:  T H Sellors; A C Thackray; A D Thomson
Journal:  Thorax       Date:  1967-05       Impact factor: 9.139

9.  The amino acid sequence of thymopoietin II.

Authors:  D H Schlesinger; G Goldstein
Journal:  Cell       Date:  1975-08       Impact factor: 41.582

10.  Myasthenia gravis, thymectomy and serum thymic hormone activity.

Authors:  J J Twomey; V M Lewis; B M Patten; G Goldstein; R A Good
Journal:  Am J Med       Date:  1979-04       Impact factor: 4.965

View more
  11 in total

1.  Gaucher disease gene GBA functions in immune regulation.

Authors:  Jun Liu; Stephanie Halene; Mei Yang; Jameel Iqbal; Ruhua Yang; Wajahat Z Mehal; Wei-Lien Chuang; Dhanpat Jain; Tony Yuen; Li Sun; Mone Zaidi; Pramod K Mistry
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  Immunohistochemical studies on a human thymic epithelial cell subset defined by the anti-cytokeratin 18 monoclonal antibody.

Authors:  W Savino; M Dardenne
Journal:  Cell Tissue Res       Date:  1988-10       Impact factor: 5.249

3.  Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-gamma) on human thymoma neoplastic epithelial cells.

Authors:  M Inoue; M Okumura; S Miyoshi; H Shiono; K Fukuhara; Y Kadota; R Shirakura; H Matsuda
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

4.  In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis.

Authors:  C Aime; S Cohen-Kaminsky; S Berrih-Aknin
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

5.  Thymic epithelium in AIDS. An immunohistologic study.

Authors:  W Savino; M Dardenne; C Marche; D Trophilme; J M Dupuy; D Pekovic; N Lapointe; J F Bach
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

6.  Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?

Authors:  N Willcox; M Schluep; M A Ritter; H J Schuurman; J Newsom-Davis; B Christensson
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

7.  Thymomatous epithelial cells and skeletal muscle share a common epitope defined by a monoclonal antibody.

Authors:  M Dardenne; W Savino; J F Bach
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

8.  Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.

Authors:  Yeonghun Lee; Sehhoon Park; Se-Hoon Lee; Hyunju Lee
Journal:  BMC Cancer       Date:  2017-05-15       Impact factor: 4.430

Review 9.  Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.

Authors:  Inga Koneczny; Ruth Herbst
Journal:  Cells       Date:  2019-07-02       Impact factor: 6.600

Review 10.  Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

Authors:  Nico Melzer; Tobias Ruck; Peter Fuhr; Ralf Gold; Reinhard Hohlfeld; Alexander Marx; Arthur Melms; Björn Tackenberg; Berthold Schalke; Christiane Schneider-Gold; Fritz Zimprich; Sven G Meuth; Heinz Wiendl
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.